Asa Rosenquist

Symmetric fluoro-substituted diol-based HIV protease inhibitors. Ortho-fluorinated and meta-fluorinated P1/P1'-benzyloxy side groups significantly improve the antiviral activity and preserve binding efficacy.

Anders Hallberg, Guido Zuccarello, L. Vrang, 2004, European journal of biochemistry.

Induced-fit binding of the macrocyclic noncovalent inhibitor TMC435 to its HCV NS3/NS4A protease target.

Susanne Nyström, Maxwell D Cummings, Oliver Lenz, 2010, Angewandte Chemie.